Detalles de la búsqueda
1.
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium.
NPJ Vaccines
; 9(1): 53, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38448450
2.
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses.
Vaccines (Basel)
; 11(2)2023 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851164
3.
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA).
Vaccines (Basel)
; 12(1)2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38250827
4.
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2.
NPJ Vaccines
; 8(1): 147, 2023 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37775521
5.
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial.
Lancet Reg Health Eur
; 28: 100613, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37131861
6.
In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?
Viruses
; 13(3)2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33803790
7.
Feasibility of using monocyte-derived dendritic cells obtained from cryopreserved cells for DC-based vaccines.
J Immunol Methods
; 498: 113133, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480950
8.
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium.
NPJ Vaccines
; 9(1): 84, 2024 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762608
Resultados
1 -
8
de 8
1
Próxima >
>>